Masonic Cancer Center, University of Minnesota

What's Inside

Quick Links for:

Cancer Information Line
Ask about cancer, clinical trials, and how to make an appointment:
ccinfo@umn.edu
612-624-2620

Toll-free in IA, MN, ND, SD, WI: 1-888-CANCER MN
(1-888-226-2376)

A Comprehensive Cancer Center Designated by the National Cancer Institute

Print this page. Mail this link to a friend.

BMT Conferences 2003-2004

Date Presenter
September 22, 2003 Transplant therapy for Multiple Myeloma:  Data Update and New Protocols Mukta Arora, M.D. Hematology, Oncology and Transplantation   Division Department of Medicine University of Minnesota
September 29, 2003 Mycophenolate Exposure in Nonmyeloablative HSCT:  Is It Relevant to Engraftment and Acute GVHD? Pamala Jacobson, Pharm. D. Assistant Professor  Experimental & Clinical Pharmacology  College of Pharmacy  University of Minnesota 
October 6, 2003 Attending meeting
October 13, 2003 Long Term Complications in Survivors after Stem Cell Transplant Part 1:

Reproductive Impairments in Survivors of Stem Cell Transplant

Gonadal Failure After BMT

Male Sexual Function Following BMT

K. Scott Baker, M.D., M.S. Assistant Professor Department of Pediatrics

Anna Petryk, M.D. Assistant Professor Department of Pediatrics

Bruce Redmon, M.D. Associate Professor Departments of Medicine and Urologic Surgery

October 20, 2003 Cancelled Cancelled
October 27, 2003 Tracking the Fate and Function of Tumor-Specific T Cells During Immune Reconstitution Hyam Levitsky, M.D. Professor of Oncology, Medicine, and Urology Sidney Kimmel Comprehensive Cancer Center  Johns Hopkins University School of Medicine  Hosted by:  Bruce Blazar, MD

November 3, 2003

CANCELED

November 10, 2003

Novel Methods to Prevent GVHD

Nelson J. Chao, MD

Professor of Medicine and Immunology

Director, BMT Program

Duke University  

Hosted by:   Bruce Blazar, M.D.

Sponsored by AMGEN

November 17, 2003

Mechanisms and Molecules in the Graft vs. Leukemia Response

Stanley Riddell, M.D.

Member, Program in Immunology

Fred Hutchinson Cancer Research Center

Professor of Medicine

University of Washington

Hosted by:   Bruce Blazar, MD

November 24, 2003

Transplant for AML: What Are We Doing and Why?

Paul Orchard, M.D.

Assistant Professor

Department of Pediatrics

December 1, 2003

ASH Practice

K. Scott Baker , MD , MS : “Late Effects In Survivors Of Related Or Unrelated Donor BMT For CML”

Ashish R. Kumar, MD, PhD :   “ Hoxa9 Influences The Phenotype But Not The Incidence of Mll -fusion Gene Leukemia”

Jeffrey S. Miller, MD :   “Adoptive Immunotherapy of Cancer Using Haploidentical Natural Killer (NK) Cell Infusions To Overcome Inhibitory Receptor Recognition of Class 1 Molecules”

December 8, 2003

No conference due to ASH

December 15, 2003

Adoptive Transfer of   Ex Vivo CD3/CD28 Stimulated T Cells for ImmuneAugmentation

Bruce Levine, M.D.

Director, Clinical Cell and Vaccine Production Facility

Abramson Cancer Center

University of Pennsylvania

Hosted by: Jeff Miller. M.D.

 

December 22, 2003

Canceled due to holidays

December 29, 2003

Canceled due to holidays

January 5, 2004

Catherine Verfaillie, M.D.

Professor, Department of Medicine

Director, Stem Cell Institute University of Minnesota

January 12, 2004

Long Term Complications in Survivors after Stem Cell Transplant Part 2:

Edward Cheng, M.D.

Professor

Orthopaedic Surgery

University of Minnesota

Avascular Necrosis

Linda Burns, M.D.

Associate Professor

Department of Medicine

University of Minnesota

Osteoporosis Study

January 19, 2004 MLK Holiday-BMT Conference Canceled 

January 26, 2004

Polyomavirus Infections Including Cystitis in HSCT Recipients

Jo-Anne van Burik, M.D.

Assistant Professor of

Medicine, Division of Infectious

Diseases & International Medicine

University of Minnesota 
February 2, 2004 Attending Meeting

February 9, 2004

A new Phase 1 Protocol:

Infusion of CD4+ CD25+ Suppressor Cells for GVHD Prevention 

Margaret MacMillan, M.D.

Assistant Professor, Department of Pediatrics, University of Minnesota

 

Wayne Godfrey, M.D.

Assistant Professor, Departments of Pediatrics and Medicine,

University of Minnesota
February 16, 2004 Canceled due to tandem meetings

February 23, 2004

Lung injury and repair post-BMT

Angela Panoskaltsis-Mortari, Ph.D., D (ABMLI), Assistant Professor, Department of Pediatrics, Hematology/Oncology And Blood and Marrow Transplantation, Pulmonary and Critical Care Medicine, University of Minnesota

March 1, 2004

Palliative care in a quaternary hospital

Mark Leenay, M.D.

Medical Director

Transition and Life Choices

Fairview University Medical Clinic

March 8, 2004

Alternatives to methotrexate in GVHD prophylaxis

Joseph H. Antin, M.D.

Chief, Stem Cell Transplant Program

Professor of Medicine

Dana-Farber Cancer Institute

Harvard Medical School

Sponsor: Fujisawa Healthcar

Host: Daniel Weisdorf

March 15, 2004

Stem Cell Transplantation for Lymphoma: Who Benefits?

Robert M. Dean, M.D. Clinical Fellow, Medical Oncology Clinical Research Unit Center for Cancer Research, National Cancer Institute Bethesda, MD

March 22, 2004

New Myeloma Protocols

Mukta Arora, M.D. Hematology, Oncology and Transplantation   Division Department of Medicine University of Minnesota

March 29, 2004 Cancelled due to Cancer Center function in 450 CCRB

April 5, 2004

New ID Guidelines and What to do with Galactomannan Assays

Jo-Anne van Burik, M.D. Assistant Professor of Medicine, Division of Infectious Diseases & International Medicine, University of Minnesota

April 12, 2004

Update on UCB Transplantation in Adults

Juliet Barker, MBBS (Hons), FRACP

Assistant Professor of Medicine Division of Hematology, Oncology and Transplantation Blood and Marrow Transplant Program

April 19, 2004

Clinical Implications of Platelet Dosing Strategies: A new Clinical Trial

Jeffrey McCullough, M.D. Professor, Department of Laboratory Medicine & Pathology American Red Cross Chair, Transfusion Medicine Director, Biomedical Engineering Institute

April 26, 2004

Immunopathology of Graft Versus Host Disease

Robert Korngold, Ph.D. Professor Kimmel Cancer Center Jefferson Medical College Philadelphia, PA Hosted by: Bruce Blazar, M.D.

May 3, 2004

Outcome of BMT for Large Cell Lymphoma

Linda Burns, M.D. Associate Professor Medicine Division of HOT University of Minnesota -and- Rachel Lerner, M.D. Hematology, Oncology and Transplantation Division Department of Medicine University of Minnesota

May 10, 2004

BMT Program Meeting

May 17, 2004

Strategies to Augment Anti-tumor Immunity in Autologous Stem Cell Transplantation

Ivan Barrello, M.D. Assistant Professor of Oncology Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hosted by: Bruce Blazar, M.D.

May 24, 2004

Outcome of Ethnic Minorities with Acute or Chronic Leukemia Treated with Hematopoietic Stem Cell Transplantation in the United States

K. Scott Baker, MD, MS Assistant Professor Pediatric Blood and Marrow Transplant Program University of Minnesota
May 31, 2004 Canceled - Memorial Day Holiday 

June 7, 2004

HHV-6 Infections: which HSCT patients should be monitored

JoAnne van Burik, M.D. Assistant Professor of Medicine, Division of Infectious Diseases & International Medicine University of Minnesota